Table 1.
Demographic Data | Group 1 (n = 23) |
Group 2 (n = 177) |
Group 3 (n = 101) |
---|---|---|---|
Sex (Male) | 18 (78.3%) | 101 (57.1%) | 64 (63.4%) |
Days between KD onset and diagnosis (minimum and maximum) |
5–19 days | 5–25 days | 5–30 days |
Days between KD onset and IVIG administration (minimum and maximum) |
6–20 days | 5–26 days | 5–32 days |
Incomplete or atypical KD presentation | 9 (39.1%) | 8 (4.5%) | 7 (6.9%) |
Group 1: ≤1 year, Group 2: ˃1 to ≤4 years, and Group 3: >4 years. KD: Kawasaki disease; IVIG: Intravenous immunoglobulin.